CompuMed Inc. (OTCMKTS:CMPD – Get Free Report) was up 0.2% on Wednesday . The stock traded as high as $6.20 and last traded at $6.20. Approximately 950 shares changed hands during mid-day trading, an increase of 72% from the average daily volume of 553 shares. The stock had previously closed at $6.19.
CompuMed Price Performance
The company has a quick ratio of 2.34, a current ratio of 2.37 and a debt-to-equity ratio of 0.12. The firm has a market cap of $8.25 million, a PE ratio of -41.33 and a beta of -0.47. The stock has a 50 day moving average price of $6.41 and a two-hundred day moving average price of $5.52.
CompuMed (OTCMKTS:CMPD – Get Free Report) last announced its quarterly earnings data on Monday, May 11th. The company reported ($0.06) EPS for the quarter. The company had revenue of $2.03 million during the quarter. CompuMed had a negative net margin of 2.51% and a negative return on equity of 6.47%.
CompuMed Company Profile
CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.
Featured Stories
- Five stocks we like better than CompuMed
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.
